Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DANISH: Adalimumab in Spondyloarthritis
NCT00477893Phase 4Unknown
- Sponsor
- Rigshospitalet Glostrup
- Start
- Feb 2006
- Primary completion
- Jan 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in spondyloarthritis (SpA), sponsored by Rigshospitalet Glostrup. Status: unknown.
02
Drugs
03
Conditions
spondyloarthritis (SpA)
Beyond the preview
Go deeper on NCT00477893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477893.